Cannabinergic nitrate esters and related analogs

US10968206B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10968206-B2
Application numberUS-201916240190-A
CountryUS
Kind codeB2
Filing dateJan 4, 2019
Priority dateFeb 26, 2013
Publication dateApr 6, 2021
Grant dateApr 6, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present technology relates to novel cannabinergic nitrate esters and related analogs, process of preparation, pharmaceutical compositions and their methods of use as medicaments, pharmacological tools and/or biomarkers. The novel cannabinergic nitrate ester compounds provide medicaments useful in treating a variety of diseases and medical disorders.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound of formula (IIa): or a pharmaceutically acceptable salt thereof; wherein: ring C is carbocyclic, bicyclic, aryl, heterocyclyl, heteroaryl, or a terpene; G is a bond, C═O, NH, CH 2 , CONN, NHCO, C(O)O, OC(O), OCH 2 , S, SO, SO 2 , or O; ring A is: R 2a and R 2b are each independently H, OH, SH, NH 2 , CF 3 , COOH, alkoxy, halogen, ONO 2 , alkyl-ONO 2 , or optionally substituted alkyl, haloalkyl, amine, amide, imide, alkoxy, alkoxy thio, phosphate, phosphonate, carboxyl, formyl, carbamyl, amino, acylamino, amido, imido, aminoalkyl, aminoaryl, heteroarylamino, heterocyclylamino, sulfonate, sulfonamide, sulfonyl, thioalkyl, thioaryl, heteroarylthio, heterocyclylthio, phosphonate, phosphate, or acetate; Y is a bond; and R 3 is alkyl, wherein the carbocyclic, bicyclic, aryl, heterocyclyl, or heteroaryl Ring C is optionally substituted with one or more substituents selected from alkyl, alkynyl, alkenyl, alcohol, halogen, hydroxyl, alkoxy, alkenoxy, alkynoxy, aryloxy, aralkyloxy, heterocyclyloxy, heterocyclylalkoxy, oxo, carboxyl, ester, urethane, oxime, hydroxylamine, alkoxyamine, aralkoxyamine, thiol, sulfide, sulfoxide, sulfone, sulfonyl, sulfonamide, amine, N-oxide, hydrazine, hydrazide, hydrazine, azide, amide, urea, amidine, guanidine, enamine, imide, isocyanate, isothiocyanate, cyanate, thiocyanate, imine, nitro, or nitrile. 2. The compound of claim 1 , wherein ring C is: 3. The compound of claim 1 , wherein: ring C is carbocyclic or heterocyclyl; ring A is heteroaromatic; G is C═O or CONH; and R 2a and R 2b are each independently Cl, OH, O-alkyl, alkyl, amino, thio, O(CO)alkyl, or OC(O)NH 2 . 4. The compound of claim 1 , wherein: C is aromatic and A is heteroaromatic, and G is C═O; C is aromatic and A is heteroaromatic, and G is CONH; C is heterocyclic and A is heteroaromatic, and G is C═O; C is carbocyclic and A is heteroaromatic, and G is C═O; C is aromatic and A is heteroaromatic, and G is NH; C is a terpene; C is carbocyclic; C is heteroaromatic and A is heteroaromatic, and G is OCH 2 ; C is aromatic and A is heterocyclic, and G is CH 2 ; C is carbocyclic and A is heteroaromatic, and G is a COO or OCO; C is heterocyclic and A is heteroaromatic, and G is a bond; C is aromatic and A is heterocyclic, and G is a bond; or C is bicyclic. 5. A compound represented by one of the following structural formulas: or a pharmaceutically acceptable salt thereof. 6. A composition comprising a compound of claim 1 , or a pharmaceutically acceptable salt thereof, and at least one pharmaceutically acceptable excipient. 7. A compound represented by the following structural formula: or a pharmaceutically acceptable salt thereof. 8. The compound of claim 1 , wherein ring A is:

Assignees

Inventors

Classifications

  • o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol · CPC title

  • having nitrate groups bound to acyclic carbon atoms · CPC title

  • Ring systems having three or more relevant rings · CPC title

  • having six-membered rings with one nitrogen as the only ring hetero atom · CPC title

  • the bicyclo ring system containing seven carbon atoms · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10968206B2 cover?
The present technology relates to novel cannabinergic nitrate esters and related analogs, process of preparation, pharmaceutical compositions and their methods of use as medicaments, pharmacological tools and/or biomarkers. The novel cannabinergic nitrate ester compounds provide medicaments useful in treating a variety of diseases and medical disorders.
Who is the assignee on this patent?
Univ Northeastern
What technology area does this patent fall under?
Primary CPC classification C07D405/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 5 related publications on this page (citations in our corpus or others sharing the same primary CPC).